$0.335
+0.008 (+2.29%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ACTU por análisis de gráficos similares
Alphio's ACTU stock price prediction model matches the current Actuate Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.34 (+2.09%). The 1-week path is $0.34 (+0.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Actuate Therapeutics Inc?
Actuate Therapeutics Inc is not a strong buy at the moment due to its current price of $0.33, which is significantly below its 52-week high of $7.90 and reflects a year-to-date change of -94.45%. The RSI is at 28.68, indicating that the stock is oversold, but the forward P/E ratio is 0, suggesting no earnings growth is expected in the near term. The main risk is the negative earnings trend, with an EPS estimate of -0.18 for the next quarter.
ACTU cerró en $0.33 el Friday, tras subir +2.29%
Actuate Therapeutics Inc (ACTU) last closed at $0.3345, gaining +2.29%. These facts feed the 1-day and 1-week ACTU price prediction above.
Factores de la previsión
Los factores de la previsión de Actuate Therapeutics Inc (ACTU) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ACTU, ordenadas por similitud.
Análisis de estacionalidad de ACTU
Historically the probability of a positive November return for ACTU is 34.09%. January offers the highest probability of a positive month at 57.50%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ACTU
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $5.77 | $6.69 | $7.86 | +1898.93% |
| Dec 2026 | $5.97 | $6.70 | $7.46 | +1904.37% |
En 2026, se proyecta que Actuate Therapeutics Inc (ACTU) oscile entre $5.77 y $7.86.
Previsión mensual de Actuate Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Actuate Therapeutics Inc promedie $6.69, con un mínimo de $5.77 y un máximo de $7.86.
En Dec de 2026, se proyecta que Actuate Therapeutics Inc promedie $6.70, con un mínimo de $5.97 y un máximo de $7.46.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.